ABSTRACT
Non-melanoma skin cancers are the most prevalent form of cancer, with cutaneous squamous cell carcinoma (cscc) being the 2nd most common type. Patients presenting with high-risk lesions associated with locally advanced or metastatic cscc face high rates of recurrence and mortality. Accurate staging and risk stratification for patients can be challenging because no system is universally accepted, and no Canadian guidelines currently exist. Patients with advanced cscc are often deemed ineligible for either or both of curative surgery and radiation therapy (rt) and, until recently, were limited to off-label systemic cisplatin-fluorouracil or cetuximab therapy, which offers modest clinical benefits and potentially severe toxicity. A new systemic therapy, cemiplimab, has been approved for the treatment of locally advanced and metastatic cscc. In the present review, we provide recommendations for patient classification and staging based on current guidelines, direction for determining patient eligibility for surgery and rt, and an overview of the available systemic treatment options for advanced cscc and of the benefits of a multidisciplinary approach to patient management.
Subject(s)
Carcinoma, Squamous Cell/therapy , Skin Neoplasms/therapy , Carcinoma, Squamous Cell/pathology , Humans , Neoplasm Metastasis , Skin Neoplasms/pathologySubject(s)
Abortifacient Agents, Steroidal/therapeutic use , Abortion, Induced/economics , Abortion, Induced/methods , Drug Synergism , Drug Therapy, Combination , Female , Gestational Age , Humans , Mifepristone/therapeutic use , Misoprostol/therapeutic use , Ontario , Pregnancy , Treatment OutcomeABSTRACT
A 75 year old man presented with metastatic carcinoma of the brain. At autopsy a primary scar adenocarcinoma of the lung was found. By light microscopy the cytoplasm of the tumor cells was seen to contain hyalin masses with tinctorial properties identical to those of the Mallory bodies seen in human alcoholic liver disease and in hepatocellular carcinoma. The hyalin stained positively with anti-Mallory body antibody by the peroxidase antiperoxidase technique, and had the characteristic filamentous and granular amorphous appearance of alcoholic hyalin by electron microscopy. Our observation is of interest in light of recent information relating Mallory bodies to prekeratin, and vitamin A deficiency to lung cancer.
Subject(s)
Adenocarcinoma/analysis , Hyalin/analysis , Lung Neoplasms/analysis , Adenocarcinoma/secondary , Adenocarcinoma/ultrastructure , Aged , Brain Neoplasms/secondary , Cicatrix , Humans , Immunoenzyme Techniques , Inclusion Bodies/ultrastructure , Lung Neoplasms/ultrastructure , Male , Microscopy, Electron , Staining and LabelingSubject(s)
Adenine Nucleotides/pharmacology , Adenine/pharmacology , Adenosine/pharmacology , Purkinje Cells/drug effects , Adenosine Diphosphate/pharmacology , Adenosine Monophosphate/pharmacology , Adenosine Triphosphate/pharmacology , Animals , Cyclic AMP/pharmacology , Electrophysiology , Iontophoresis , Male , Rats , Structure-Activity RelationshipABSTRACT
Adenosine and several adenine nucleotides depress the excitability of cerebral cortical neurones, including identified Betz cells. Cyclic 3',5'-adenosine monophosphate was a less effective depressant than various other adenine nucleotides, including cyclic 2',3'-adenosine monophosphate. Adenine and inosine had only weak depressant activity. An initial excitant action of ATP was observed on several neurones. This was succeeded by a depressant effect when the application of ATP was terminated.